The Regan-Udall Evaluation – Something New or Same Old Story?
Evaluations of FDA’s performance and programs are nothing new. Just this year, the agency has been the subject of reviews by Congress, GAO, AFDO, its
Day: December 13, 2022
Evaluations of FDA’s performance and programs are nothing new. Just this year, the agency has been the subject of reviews by Congress, GAO, AFDO, its
